Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools

Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, announces that it has completed its merger with SomaLogic, creating a leading provider of differentiated multi-omics tools for research. Each SomaLogic stockholder will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. SomaLogic common stock and public warrants have ceased trading and will no longer be listed on the NASDAQ Global Select Market.

Read the full article: Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences Tools //

Source: https://www.globenewswire.com/news-release/2024/01/05/2804664/0/en/Standard-BioTools-Completes-Merger-with-SomaLogic-Creating-a-Diversified-and-Scaled-Leader-in-Life-Sciences-Tools.html

Leave a Comment

Your email address will not be published.

Scroll to Top